Moreover, DLX4 hypermethylation, with a role in silencing DLX4 expression, is associated with disease evolution in uterine cervical low-grade squamous intraepithelial lesions (LSILs) and non-small cell lung cancer (NSCLC) [22, 23]. The gene discussed is DLX4; the disease is non-small cell lung carcinoma.